During the past decade, RoMed Klinikum Rosenheim, Medizinische Klinik III conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "RoMed Klinikum Rosenheim, Medizinische Klinik III" are "Idiopathic Pulmonary Fibrosis" (1 trials) and "Non-Small Cell Lung Cancer (NSCLC)" (1 trials). Many other conditions were trialed in "RoMed Klinikum Rosenheim, Medizinische Klinik III" in a lesser frequency.

Most popular intervention types in "RoMed Klinikum Rosenheim, Medizinische Klinik III" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials) and "Pirfenidone" (1 trials). Other intervention names were less common.

The vast majority of trials in "RoMed Klinikum Rosenheim, Medizinische Klinik III" are 2 trials for "All" genders.

Currently, there are NaN active trials in "RoMed Klinikum Rosenheim, Medizinische Klinik III". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in RoMed Klinikum Rosenheim, Medizinische Klinik III, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in RoMed Klinikum Rosenheim, Medizinische Klinik III, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".